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Abstract
Objective The aim of the present study was to examine the relationship between serious arrhythmias in
patients with psychotropic drug overdose and electrocardiography (ECG) findings that have been
suggested previously to predict this complication.
Methods Thirty-nine patients with serious arrhythmias (ventricular tachycardia, supraventricular
tachycardia or cardiac arrest) after tricyclic antidepressant overdose or thioridazine overdose were
compared with 117 controls with clinically significant overdose matched to each case for the drug
ingested. These patients with psychotropic drug overdose had presented for treatment to the
Department of Clinical Toxicology, Newcastle and to the Princess Alexandra Hospital, Brisbane. The
heart rate, the QRS width, the QTc and QT intervals, the QT dispersion, and the R wave and R/S ratios
in aVR on the initial ECGs were compared in cases and controls.
Results The cases had taken dothiepin (16 patients), doxepin (six patients), thioridazine (five patients),
amitriptyline (five patients), nortriptyline (three patients), imipramine (one patient) and a combination of
dothiepin and thioridazine (three patients). In 20 of the 39 patients with arrhythmias, the arrhythmia had
been a presumed ventricular tachycardia. Of the other 19 patients, 15 patients had a supraventricular
tachycardia, two patients had cardiac arrests (one asystole, one without ECG monitoring) and two
patients had insufficient data recorded to make classification of the arrhythmias possible. The QRS
was ≥100ms in 82% of cases but also in 76% of controls. QRS≥160ms had a sensitivity of only
13% and occurred in 2% of controls. QRS >120ms, QTc>500 and the R/S ratio in aVR appeared to
have a stronger association with the occurrence of arrhythmia: QRS>120ms (odds ratio [OR], 3.56;
95% confidence interval [CI], 1.46–8.68), QTc>500 (OR, 3.07; 95% CI, 1.33–7.07), and R/S ratio in
aVR>0.7 (OR, 16; 95% CI, 3.47–74). Excluding thioridazine overdoses and performing the analysis
for tricyclic antidepressant overdoses alone gave increased odds ratios for QRS>120ms (OR, 4.83;
95% CI, 1.73–13.5) and QTc>500 (OR, 4.5; 95% CI, 1.56–13) but had little effect on that for the
R/S ratio in aVR>0.7 (OR, 14.5; 95% CI, 3.10–68).
Conclusion ECG measurements were generally weakly related to the occurrence of arrhythmia and
should not be used as the sole criteria for risk assessment in tricyclic antidepressant overdose. The
frequently recommended practice of using either QRS≥100ms or QRS≥160ms to predict arrhythmias
is not supported by our study. R/S ratio in aVR>0.7 was most strongly related to arrhythmia but had
estimated positive and negative predictive values of only 41% and 95%, respectively. The use of these
specific predictors in other drug overdoses is not recommended without specific studies.
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Introduction
Psychotropic drugs with cardiotoxic effects, taken frequently
in overdose, are among the most common causes of death
from overdose [1,2]. The majority of deaths occur out of hos-
pital, however; the inhospital mortality is quite low (<2%)
[3–5]. As only a small proportion of these patients have life-
threatening complications, efforts have been made to identify
those at risk using findings on the electrocardiograph. The
electrocardiography (ECG) findings examined have included
the QRS duration, the QT interval duration, and the axis of the
terminal 40ms of the QRS complex represented by the
height of the R wave and the R/S ratio in aVR [6–20]. As well
as using ECG findings to predict risk of arrhythmias, some
authors use ECG criteria to predict the risk of noncardiac
complications such as coma or seizures. But the risk of
seizures and other complications varies widely between anti-
depressants [4,21,22], and may be due to mechanisms unre-
lated to the cardiac effects of these drugs [23]. This fact is
supported by the observation that the increase in seizure risk
for dothiepin is independent of the ECG findings [4].
Another problem with ECG indicators of risk is that many
studies have used nonstandardised observations. As there is
substantial inter-rater variation in measuring even simple ECG
findings in overdose [24], doubt must be cast on the validity
of such observations. Second, the use of post hoc analysis
means that the sensitivity and specificity of suggested ‘cut-
points’ usually have been overestimated. Finally, some studies
have combined a number of trivial ‘complications’ as out-
comes (e.g. ventricular ectopic activity) with more serious
complications. These data cannot be used to predict only the
more serious adverse events. The important clinical decision
in the emergency setting is which patients should have con-
tinuous electrocardiographic monitoring for arrhythmias.
These ECG predictors have been based on studies of tri-
cyclic antidepressant (TCA) poisoning. However, they are
often loosely applied to patients who take drugs with appar-
ently qualitatively similar cardiotoxicity, such as antipsychotic
drugs, antihistamines and antiarrhythmic drugs. The most
closely related drugs are antipsychotic drugs that have a
similar tricyclic structure, such as phenothiazines. For
example, thioridazine causes similar ECG changes to TCAs
and commonly causes ventricular arrhythmias in overdose
[25]. Experimentally, thioridazine also blocks ion channels in
the heart and causes early after-depolarisations, in a similar
manner to some TCAs [26].
The aim of the present study was to examine the usefulness
of all the previously suggested ECG findings in predicting
serious arrhythmias in patients with overdose of TCAs and of
antipsychotic drugs. In addition, as QT dispersion has been
used as a marker for arrhythmia in patients with ischaemic
heart disease and cardiac failure [27–29], we examined the
usefulness of QT dispersion as a predictor of arrhythmias in
these overdoses.
Patients and methods
We identified patients with arrhythmias from two clinical data-
bases. All cases recorded as having arrhythmias after TCA
overdose or antipsychotic drug overdose were selected. No
patients had a known cardiac history. While ingestion of other
drugs was common, no patient had ingested other drugs that
were believed to be a more probable cause of the arrhythmia
in any of these cases. We have made the assumption that the
purpose of the ECG is to identify patients at risk of any sus-
tained arrhythmia, and therefore arrhythmias were defined as
sustained tachyarrhythmias (supraventricular tachycardia
[SVT] or ventricular tachycardia [VT]), complete heart block
or asystole.
The cases recorded in the Department of Clinical Toxicol-
ogy database, Newcastle include all patients who pre-
sented to hospital between 1987 and 1995. The Princess
Alexandra Hospital, Brisbane only recorded data on patients
who were admitted with overdose (not the substantial
number who were discharged from the emergency depart-
ment) between 1986 and 1995. Our institutions do not
require Human Research Ethics Committee approval to
collect, analyse or publish data involving audit of usual clini-
cal practice.
For all patients who were recorded as having arrhythmias, the
first ECG recorded was reviewed. If this ECG was reported
as showing an arrhythmia, the first ECG taken as soon as
possible after reversion of the arrhythmia was used (this
affected 10 out of 39 cases).
Original medical records of all patients who had been
recorded as having an arrhythmia were reviewed. Controls
were selected from patients who had ingested the same
drug, had a potentially severe TCA overdose or antipsy-
chotic drug overdose (>1500mg ingested or significant tox-
icity — coma or seizures) and who did not experience
arrhythmias. It was not possible to find three matched (for
drug-ingested) controls for cases with nortriptyline over-
doses or dothiepin and thioridazine in combination over-
doses. Other TCA overdoses were used to match cases of
nortriptyline. Dothiepin-only ingestions were used to match
dothiepin and thioridazine combinations. The ECGs were
reviewed by two cardiologists (SC and JL). Wide complex
tachycardia were classified as VT except when the ECG
morphologies in sinus rhythm and in tachycardia were not
significantly different. These arrhythmias and narrow complex
tachycardia were classified as SVT [30].
Every ECG was magnified (×1.4) using a high-quality photo-
copier (Konica 3135, Konica, Tokyo, Japan). Intervals were
measured manually by one observer blinded to the case or
control status using the computer program SigmaScan
(version 3.90; SigmaScan, SPSS, Chicago, IL, USA) and a
Kurta IS-1 digitising pad (Altek Corporation, SIlver Spring,
MD, USA).R103
The QT interval was measured from the earliest QRS deflec-
tion to the end of the T-wave, defined as the point of return of
the T wave to the isoelectric baseline. If the end of the T wave
could not be determined reliably, the lead was not included.
The QTc was calculated using Bazett’s formula [31]. The
height of the R wave in aVR above the isoelectric line and the
ratio of this to the depth of the S wave below the line were
measured using the method described by Leibelt and col-
leagues [8]. The QT and JT dispersions were the difference
between the minimum and maximum QT and JT intervals. The
adjusted QT (and JT) dispersion is the QT (JT) dispersion
divided by the square root of the number of leads used for
QT (JT) measurements [32].
Statistical analysis
Subjects who had arrhythmias were compared with matched
individuals who had ingested the same drug with respect to
age, gender, and the amount ingested. To investigate the
strength of the association between a variety of study factors
and arrhythmia, the odds ratio (OR) of exposure to the study
factor in those with and without the outcome was calculated
using the Mantel–Haenszel method for matched sets. ORs
were adjusted for age and gender, and the effect of other
study factors using conditional logistic regression. ORs for
QRS measurements were adjusted for the QTc duration,
and other ECG findings were adjusted for the QRS duration
to determine whether the associations were independent of
other commonly used predictors.
Results
Thirty-nine patients developed significant arrhythmias (SVT,
VT or cardiac arrest). All arrhythmias occurred within
24 hours of presentation and were attributed to the overdose.
Three of these patients died: one with an asystolic arrest, one
with VT followed by cardiac arrest, and one with refractory VT
and hypotension. Arrhythmias occurred in 2% (13/630) of
TCA overdoses and in 4% (6/147) of thioridazine overdoses
in Newcastle. No arrhythmias occurred in patients ingesting
other antipsychotic drugs (0/289). Arrhythmias were also
uncommon in Brisbane; however, the total number of psy-
chotropic drug overdoses in the area was not known.
On review, 20 patients had a presumed VT. In the other
19 patients, 15 patients had SVT, two patients had cardiac
arrests (one asystole and one without ECG monitoring) and
two patients had a tachyarrhythmia for which classification
was not possible because the record of the arrhythmia was
not in the chart. The drugs taken by cases with arrhythmia
were dothiepin (16 patients), doxepin (six patients), thiori-
dazine (five patients), amitriptyline (five patients), nortriptyline
(three patients), imipramine (one patient), and a combination
of dothiepin and thioridazine (three patients).
Descriptive data for patients with arrhythmias (cases) and
controls are presented in Table 1. The cases and controls
had a similar age, a similar gender and a similar dose
ingested (although these were not matched a priori). The
relationship between arrhythmia and various ECG findings is
presented in Table 2 (analysed as continuous variables) and
in Table 3 (using dichotomised variables based on previously
described cutpoints or on the median). Adjustment for age
and gender had no substantial effect on the ORs (data not
shown). Adjustment for other ECG variables significantly
lowered the ORs, however, indicating that they may be mea-
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Table 1
Comparison of study variables and electrocardiography measurements on initial electrocardiograms in those with and without
arrhythmias
Ventricular
Controls Cases tachycardia
(n = 117) (n = 39) (n = 20)
Age (years) 32 (14–71) 31 (15–49) 34 (18–49)
Male (%) 46 41 30
Amount (mg) 2250 (450–10,000) 2325 (500–6250) 2375 (1000–6250)
Heart rate (beats/min) 101 (62–151) 111 (68–176) 115 (68–163)
QRS (ms) 100 (70–160) 115 (80–205) 120 (80–205)
QT (ms) 390 (280–537) 396 (255–550) 400 (255–540)
QTc 500 (404–735) 538 (420–693) 554 (420–693)
QT dispersion 51 (10–190) 67 (28–150) 65 (36–150)
Corrected QT dispersion 16 (3–55) 20 (9–65) 20 (11–43)
JT dispersion 50 (20–154) 63 (30–163) 63 (30–160)
R wave in aVR (ms) 1 (0–42) 3.9 (0–61) 5.5 (0–61)
R/S wave ratio in aVR 0.07 (0–1.72) 0.4 (0–1.97) 0.52 (0–1.74)
Values presented as median (range) except for gender.R104
suring different aspects of the same electrophysiological
abnormality.
The QRS, the QTc and the R/S ratio in aVR appeared to be
most strongly related to arrhythmia, although there was no
clear separation of the groups. The raw data (Figs1–3) indi-
cate that the relationship may be stronger when TCAs were
ingested as compared with thioridazine ingestion, but the
number of thioridazine cases was too small to make firm con-
clusions. Excluding cases and controls with thioridazine over-
dose and repeating the analysis for TCA overdoses alone
gave increased ORs for QRS>120ms (OR, 4.83; 95% con-
fidence interval [CI], 1.73–13.5) and QTc>500 (OR, 4.5;
95% CI, 1.56–13) but had little effect on that for the R/S
ratio in aVR>0.7 (OR, 14.5; 95% CI, 3.10–68). The ECG
findings in patients with VT were not markedly different from
those for all cases except for the relationship between QRS
duration and arrhythmia, which may be stronger for TCA over-
doses and wide complex tachycardia (Fig.1).
Discussion
In the present study we have shown that significant arrhyth-
mias are an uncommon complication of TCA overdose or
antipsychotic drug overdose. A large number of ECG findings
are significantly related to this life-threatening complication.
However, none of the previously suggested cutpoints were
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Table 2
Unadjusted odds ratios for each electrocardiography
measurement from conditional logistic regression
Odds ratio 95% confidence interval
Heart rate (beats/min) 1.28 1.07–1.53
QRS (ms) 1.36 1.13–1.62
QT (ms) 1.04 0.98–1.11
QTc 1.08 1.02–1.14
QT dispersion 1.12 1.00–1.26
Adjusted QT dispersion 1.58 1.08–2.32
JT dispersion 1.12 1.00–1.25
R wave in aVR (mm)a 1.62 1.16–2.24
R/S ratio in aVRb 3 1.66–5.40
Odds ratios refer to a 10-unit change. a Odds ratio refers to a 5-unit
change. b Odds ratio refers to a 0.5-unit change.
Table 3
Relationship between dichotomised variables, based on measurements of initial electrocardiography and ‘arrhythmia’
Cases (%) Controls (%) Odds ratio Adjusted odds ratio
(n = 39) (n = 117) (95% confidence interval) (95% confidence interval)
Heart rate > 100 beats/min 64 51 1.68 (0.80–3.52) 1.44 (0.65–3.18)a
QRS ≥ 100 ms 82 76 1.47 (0.57–3.79) 0.87 (0.31–2.47)b
QRS >120 ms 28 9 3.56 (1.46–8.68) 2.02 (0.66–6.17)b
QRS ≥ 160 ms 13 2 14 (1.52–129) 5.42 (0.50–59)b
QT >400 ms 38 35 1.17 (0.54–2.51) 0.57 (0.23–1.43)a
QTc > 500 74 50 3.07 (1.33–7.07) 1.48 (0.57–3.87)a
R wave in aVR > 3 mm 56 29 33 (3.17–921)c 13.0 (1.64–102)a
R/S ratio in aVR > 0.7 28 3 16 (3.47–74) 8.88 (1.73–45)a
QT dispersion > 60 ms 79 62 2.67 (1.03–6.91) 1.50 (0.56–4.00)a
a Adjusted for QRS. b Adjusted for QTc. c Exact confidence interval.
Figure 1
QRS duration on initial electrocardiography according to whether
patients developed arrhythmias after tricyclic antidepressant (TCA)
overdose or thioridazine overdose. VT, ventricular tachycardia.
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sensitive enough or specific enough to use as the sole
method of risk determination. As part of an overall assess-
ment of patients in the emergency setting, the QRS, the QTc
and the terminal 40ms right axis deviation (height of the
R wave and R/S ratio in aVR) appear most strongly related to
the risk of arrhythmias. They also appear to be more strongly
related for TCA overdoses than for thioridazine overdoses.
The calculated predictive values, presented in Table 4, illus-
trate the limited utility of even these ECG findings. The QT
and JT dispersions, although related to the development of
arrhythmias, were not significantly better than the other mea-
sures and are considerably more difficult to measure.
It is difficult to compare our data directly with other data that
have been published. Most authors have studied less serious
outcomes and included less than 10 patients with life-threat-
ening arrhythmias. Nevertheless, Boehnert and Lovejoy
stated that “a QRS<100ms indicated a negligible risk of
seizures or arrhythmias, a QRS≥100ms and <160ms indi-
cated a moderate risk of seizures but a negligible risk of
arrhythmias and a QRS≥160ms indicated a high risk of both
complications” [6]. This has been widely quoted (and mis-
quoted, as >100ms and 160ms rather than ≥100ms and
160ms) [33,34], although not replicated by ourselves or
other workers [8,11,15,17].
The present study provides further evidence that the R/S ratio
in aVR may be a better predictor of complications
[8,11,15,17]. Examination of the adjusted ORs indicates that
many of the ECG findings may reflect the same underlying
electrophysiological disturbance. The R/S ratio in aVR was
the only ECG measurement that remained statistically signifi-
cantly associated with arrhythmias after adjustment for
another ECG measurement (QRS). It was suggested by the
authors who described this association that the right bundle
may be more susceptible to TCA-induced conduction block
[13]. Thus, the increased R/S ratio in aVR may be providing
additional information about the nature of electrophysiologic
disturbance.
The strengths of our study include larger numbers of patients
with significant arrhythmias, the use of blinded, standardised
observations and our analysis of previously suggested thresh-
olds. There are, however, some limitations of our study. We
used a matched case–control design, in contrast to most pre-
vious studies that have examined cohorts. This was to allow
us to perform a very detailed examination of each ECG, which
would not have been practical with more than 1000 controls.
This has allowed us to compare the performance of the differ-
ent measurements and thresholds with much higher precision
and control for drugs ingested. However, it means that the
relatively poor sensitivity, specificity and predictive values pre-
sented in Table 4 are calculations where the controls are
assumed to be typical of all patients ingesting these drugs
without arrhythmias. This may be an overly conservative
assumption as the rate of arrhythmias varies substantially
between these drugs [4,25], and we did not include minor
poisonings in our control group.
The use of these ECG predictors in patients who take closely
related drugs such as thioridazine appears rational. These
phenothiazines are also weak bases with a tricyclic structure;
they block sodium and potassium channels in the heart and
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Figure 2
QTc duration on initial electrocardiography according to whether
patients developed arrhythmias after tricyclic antidepressant (TCA)
overdose or thioridazine overdose. VT, ventricular tachycardia.
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Figure 3
R/S ratio in aVR on initial electrocardiography according to whether
patients developed arrhythmias after tricyclic antidepressant (TCA)
overdose or thioridazine overdose. VT, ventricular tachycardia.
0.7
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
2.0
0.7
TCAs thioridazine
controls other arrhythmias, VT,
R/S ratio in aVRR106
cause early after-depolarisations in animal studies [26,35],
and they cause similar ECG changes and ventricular arrhyth-
mias in overdose [25]. However, our study provides no
support for this practice. The raw data illustrated in Fig 1–3
again illustrate that ECG abnormalities are common in thiori-
dazine overdose, but these do not appear to show any signifi-
cant correlation with the occurrence of arrhythmias. This
surprising finding should ideally be confirmed in another
larger study focusing solely on this drug group.
The accuracy of the ECG must be influenced by the time
from ingestion. An ECG performed shortly after TCA inges-
tion is much more likely to be normal than an ECG 4 hours
after ingestion. It is often recommended to perform ECGs
more than once, but this clinical practice has not been
assessed in any studies. Moreover, neither our study nor any
previous studies have been large enough to evaluate the
effect of elapsed time between the TCA ingestion and the
ECG criteria.
Future studies will ideally evaluate a strategy that more
closely resembles current expert clinical practice; for
example, evaluating the best ECG predictors in combination
at two different times. This should be tested in much larger,
prospective cohort studies to see whether a strategy can be
found that is sufficiently sensitive and yet is able to safely
identify the majority of patients who are not at significant risk
of arrhythmia. We would suggest that a good starting point
would be to use the cutpoints with the highest likelihood
ratios from our study (QRS >120ms, QTc>500 and R/S
ratio in aVR>0.7) at defined times (e.g. on admission and
2 hours later). Only those without any abnormalities at any
time would be considered low risk. Other patients would be
monitored until their ECG abnormalities resolve, although the
risk of arrhythmias occurring for the first time after 24 hours of
monitoring is very low.
Using measures that are capable of being measured by an
ECG machine in the emergency department would simplify
matters greatly for such a study, which would need to be con-
ducted in multiple centres to be completed within a feasible
time frame. However, this would probably require purpose-
built software for the R/S ratio in aVR, the measurement with
the best predictive performance.
Implications for management
Our results show that there is no sufficiently good
predictor(s) that can be applied to only the initial ECG to
identify patients that should have continuous electrocardio-
graphic monitoring for arrhythmias. The calculated negative
predictive values (Table 4) mean that we would expect 4–6%
of unmonitored patients to have arrhythmias, and this could
not be considered acceptable. We would recommend a strat-
egy similar to that we propose for a prospective trial. The trial
should bear in mind that such a strategy, although often rec-
ommended, has never been validated. A more conservative
strategy may be appropriate for other proarrhythmic drugs
until more data are available on prediction for other drug
classes. Based on the positive predictive values, specific
treatment to prevent arrhythmias, such as systemic alkalinisa-
tion, would be justified for all patients with QRS>120ms or
R/S ratio >0.7 in aVR. As hypoxia and acidosis increase
cardiac excitability directly, and seizures often precede
cardiac arrests and arrhythmias [4,8], patients with hypoxia,
acidosis, seizures or other significant noncardiac complica-
tions also should receive specific treatment.
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Key messages
• Serious arrhythmias after TCA and thioridazine 
overdose occur in a small but significant minority of
patients. The initial ECG is often used to predict the
need for monitoring
• A QRS >120 ms, QTc >500 and an increased R/S
ratio in aVR on the first ECG have the strongest 
association with the occurrence of arrhythmia in TCA
overdose. However, predictive values have 
unacceptably high false positive and negative rates
• These measures had a much weaker association with
arrhythmia in thioridazine than in TCA overdose
(although numbers were small). Any predictive strategy
needs validation in each drug class where it is applied
• We believe a more complex algorithm factoring in 
multiple measurements, multiple ECGs and the effect
of time may provide a much more accurate approach
to predicting the need for monitoring in TCA overdose
Table 4
Calculated positive and negative predictive values for
arrhythmia from electrocardiography cutpoints based on
incidence of arrhythmias in significant tricyclic antidepressant
poisonings (seizures, coma or ingested dose > 1.5 g) in
Newcastle (7%)
Positive Negative
predictive predictive Likelihood
value (%) value (%) ratio
QRS ≥100ms 7.5 94.7 1.08
QRS >120ms 19 94.4 3.11
QRS ≥160ms 32.8 93.7 6.5
QTc (Bazett’s) >500 10.0 96.2 1.48
R wave in aVR>3mm 12.7 95.5 1.93
R/S ratio in aVR>0.7 41.2 94.7 9.33R107
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